Terazosin
NDC 70518-0317, Terazosin Hydrochloride, capsule, from REMEDYREPACK INC..
- Product NDC
- 70518-0317
- Status
- Listed
- Labeler
- REMEDYREPACK INC.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075317
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TERAZOSIN HYDROCHLORIDE5 mg/1
Pharmacologic classes
Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70518-0317-0 | 70518031700 | 30 CAPSULE in 1 BLISTER PACK (70518-0317-0) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/854b64ff-c138-45af-9cdf-6c23323d8490
Use it
Look up 70518-0317 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70518-0317 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70518-0317. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.